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Abstract
Head and neck cancers includes oral, nasal and 
paranasal, nasopharyngeal, mesopharyngeal, 
hypopharyngeal, laryngeal, and salivary gland 
cancers, as well as cancers that involve the 
thyroid gland, ear, trachea, face, and neck. 
Epidemiological analysis of head and neck cancer 
cases in a single institution during a short period 
is extremely difficult because of its low incidence. 
We here assessed the epidemiology of head and 
neck cancer throughout Niigata Prefecture, and 
included changes in clinical features and 
treatment results from a single institution (Niigata 
University). A total of 8,572 cases were registered 
in the Niigata Prefecture Head and Neck 
Malignant Tumor Registration Committee 
database over 25 years, and the most common 
sites were larynx, followed by the oral cavity and 
thyroid gland. A tendency of an increasing 
number of cases and advanced patient ages was 
observed in head and neck cancer cases. In the 
Department of Otolaryngology, Niigata 
University School of Medicine, 1,288 cases of 
head and neck cancer were treated over a 20-year 
period. Data of Niigata University showed a 
predominance of hypopharyngeal, nasal and 
paranasal, mesopharyngeal, and ear cancer cases. 
The 5-year survival rates of tongue, oral floor, 
nasopharyungeal, hypopharyngeal cancer cases 
that underwent pharyngolaryngectomy and 
pharyngolaryngoesophagectomy, and stage IV 
laryngeal, and ear cancer cases that underwent 
surgery were excellent (73.8%, 58.9%, 71.2%, 
58.5%, 67.2%, and 82.4%, respectively). Further 
analysis of the data of Niigata Prefecture and 
Niigata University is required to keep abreast of 
advances in head and neck cancer treatment.
Introduction
‘Head and neck’ cancers are malignancies that 
occur above the shoulder with the exception of 
the intracranial and orbital regions. According to 
the “General Rules for Clinical Studies on Head 
and Neck Cancer” formulated by the Japan 
Society for Head and Neck Cancer, head and neck 
cancers occur in 7 regions: (1)the lips and oral 
cavity, (2)nasal cavity and paranasal sinuses, (3)
nasopharynx, (4)mesopharynx, (5)hypopharynx, 
(6)larynx, and (7)salivary glands [1]. However, 
other malignancies that occur in the thyroid 
gland, ear, trachea, face, and neck are also 
recognized as head and neck cancers.
Clinical features of head and neck cancer 
include the following: (1)According to the scarce 
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compared to malignancy of the other sites, 
advanced cases are common due to late diagnosis, 
because of patients lacked the knowledge on head 
and neck cancer; (2)a high percentage of 
metastatic lymph nodes in the neck; (3)
involvement of fatal functional disorders such as 
respiration and swallowing; and (4)involvement 
of communication disorders such as speech and 
hearing [2]. In addition, tobacco smoking and 
chronic alcohol consumption are risk factors for 
head and neck cancer, and complications from 
other malignancies (e.g., cancers of the esophagus 
and lung as well as other malignancies involving 
the head and neck) occurs in a high percentage of 
head and neck cancer cases [3-5]. Furthermore, 
treatment standardization is difficult because of 
the rarity of head and neck cancer cases, and the 
subsequent lack of study participants outside a 
large cancer center.
We here assessed the epidemiological data of 
head and neck cancer cases from the database of 
the Niigata Prefecture Head and Neck Malignant 
Tumors Registration Committee, Niigata 
Prefecture, Japan in a retrospective multiple-
center study. Secondly, the incidence of specific 
diseases and results of head and neck cancer cases 
treated at Niigata University, as a single medical 
institution in the prefecture, is discussed.
Part I: The basic data on head and neck cancer 
in Niigata Prefecture, Japan
In 1986, the Niigata Prefecture Head and Neck 
Malignant Tumor Registration Committee was 
founded by the Departments of Otolaryngology 
of 23 hospitals. It began to survey the 
epidemiology of head and neck cancer throughout 
Niigata Prefecture [6]. Disease surveillance was 
conducted for 25 years until 2010, and then 
commenced again. Head office of the Niigata 
Prefecture Head and Neck Malignant Tumor 
Registration Committee has been set up in the 
Department of Head and Neck Surgery, Niigata 
Cancer Hospital, and annual meeting has been 
held once a year to confirm data validation of 
registered cases. Between 1986 and 2010, a total 
8,572 head and neck cancer cases were identified, 
and the most common cancers in descending 
order were laryngeal (2,394 cases; 27.9%), 
thyroid (1,488 cases; 17.4%) and oral (1,112 
cases; 13.0%) (Figure 1). The rate of laryngeal 
cancer was similar to that in a report of 14-year 
surveillance conducted by the Niigata Prefecture 
Figure 1. Head and neck cancer cases registered in the Niigata Prefecture Head and Neck Malignant Tumor 
Registration Committee over a 25-year period (1986-2010).
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Head and Neck Malignant Tumor Registration 
Committee between 1986 and 1999 [3]. However, 
patients with thyroid and oral cancers (the second 
and third most common diseases) were treated in 
departments other than otolaryngology: therefore, 
construction of an inclusive database is necessary 
to completely elucidate the epidemiology of 
thyroid and oral cancers.
Part II: Incidence of head and neck cancer 
cases treated at Niigata University
The incidence of head and neck cancer cases 
treated at the Department of Otolaryngology, 
Niigata University School of Medicine over a 20-
year period (1991-2010) was retrospectively 
analyzed using medical records and incidence 
feature was discussed by comparing with the 
database of the Niigata Prefecture Head and Neck 
Malignant Tumor Registration Committee. 
Clinical data of the registered cases has been 
presented to the department members annually 
and data validation has been discussed. During 
this period, a total of 1,288 head and neck cancer 
cases were treated, of which the most common in 
the descending order were laryngeal (277 cases; 
21.5%) oral (201 cases; 15.6%), and hypopharyngeal 
(159 cases; 12.3%) (Figure 2). The number of 
laryngeal and thyroid cancer cases reported by 
Niigata University was relatively lower than that 
reported by the Niigata Prefecture Head and Neck 
Malignant Tumor Registration Committee, 
whereas the number of hypopharyngeal, nasal and 
paranasal, mesopharyngeal, and ear cancer cases 
reported by Niigata University was relatively 
higher. The number of consultations to laryngeal 
and thyroid cancer patients at Niigata University 
was fewer since the majority patients with these 2 
diseases were treated at local hospitals. At Niigata 
University, hypopharyngeal and ear cancer 
patients are supposed to be consulted frequently, 
because there is a wide range of treatments 
available for these 2 diseases. The total number 
of head and neck cancer cases doubled during the 
20-year period from 1991 to 2010, and the 
number of individual types tended to increase 
with the largest surge in hypopharyngeal cancer, 
which dominated the surge in laryngeal cancer, 
the most common head and neck cancer, during 
the 3-year period from 2008 to 2010 (Figure 3). 
The increase in total hypopahryngeal cancer cases 
Figure 2. Head and neck cancer cases treated at the Department of Otolaryngology, Niigata University 
School of Medicine, over a 20-year period (1991-2010).
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may have been due to the increased number of 
consultations performed at Niigata University, 
which has a large otolaryngology department 
staff. Furthermore, the 6-major cancers (oral, 
nasa l  and paranasal ,  nasopharyngeal , 
mesopharyngeal, hypopharyngeal, and laryngeal) 
have clinical features similar to those of head and 
neck cancer and were also evaluated because they 
were defined as “squamous cell carcinomas in the 
luminar organs”. The mean patient age in these 
6-major cancers has been increasing (59.6 years 
in 1991 to 68.7 years in 2010), demonstrating an 
obvious tendency of late onset in head and neck 
cancer cases. During this 20-year period, surgery 
has been the primary treatment for oral cancer, 
and the number of surgeries performed for 
hypopharyngeal and laryngeal cancers has 
decreased. Most surgeries for oral cancer cases 
were performed for early diagnosis and resection, 
since the frequency of multiple cancers within the 
oral cavity is high, and lower number of 
hypopharyngeal and laryngeal cancer surgeries is 
likely a result of the increased use of 
chemoradiotherapy and endoscopic resection for 
organ preservation.
Part III: Details of Head and Neck Cancer in 
Niigata University
1. Oral cancer [7]
A total of 118 oral cancer cases involving 135 
sites, which were treated at the Department of 
Otolaryngology, Niigata University School of 
Medicine during a 15-year period between 1991 
and 2005 were clinically analyzed. The most 
dominant subsite was the tongue, followed by the 
oral floor, cheek mucosa, gingiva, lip, and hard 
palate. The mean patient age was 63 years, and 
the ratio of male to female was 1.9:1. Stage I, II, 
III, and IV cases accounted for 16.3, 20.7, 22.2, 
and 40.7% of all oral cancer cases treated at 
Niigata University. The distribution of subsites 
and stages demonstrated that communication 
between the faculties of the Department of 
Medicine and Dentistry of Niigata University is 
important, as the number of multiple 
malignancies in oral cancer cases was re-
confirmed by the high-frequency multiple 
malignancies throughout the body and within the 
oral cavity. Our policy of surgery-oriented 
therapeutic strategy revealed an excellent 
5-yeares survival rates of 73.8% in tongue cancer 
Figure 3. Treatment course of patients with any of the 6 main cancers (oral, nasal and paranasal sinus, 
nasopharyngeal, mesopharyngeal, hypopharyngeal, and laryngeal cancer) over a 20-year period (1991-
2010). PS: paranasal sinus.
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cases and 58.9% in oral floor cancer cases (Figure 
4). Since the prognosis of cases receiving 
radiotherapy without surgery was poor, the 
treatment strategy for patients who refuse surgery 
involves oral cancer education and frequent 
clinical visit to clinics, especially in cases at 
inoperable stages.
2. Nasopharyngeal cancer [8,9]
A total of 41 nasopharyngeal cancer cases were 
treated at the Department of Otolaryngology, 
Niigata University School of Medicine during a 
17-year period between 1991 and 2007. The mean 
patient age was 53 year, and the ratio of male-to-
female was 3.7:1. As a characteristic distribution 
of age, 6 cases involved patients aged under 30 
years. The most common complaint was ear 
symptoms due to Eustachian tube obstruction in 
the nasopharynx, followed by neck swelling due 
to neck lymph node metastasis, neurological 
symptoms due to cranial base invasion, and nasal 
symptoms due to choana occlusion. The most 
common histopathological finding was squamous 
cell carcinoma followed by undifferentiated 
carcinoma, adenocarcinoma, spindle cell 
carcinoma, and malignant melanoma. For 
squamous cell carcinoma cases, concurrent 
chemoradiotheray using platinum agents with 
fluorouracil followed by adjuvant chemotherapy 
was most often administrated. The disease-
specific 5-year survival rate was excellent at 
71.2%. The differences between stage I+II and 
III+IV and stage I+II+III and IV were not 
statistically significant by using Kaplan-Meyer 
method (Figure 5). The recurrence rate was 
24.4%, and distant metastasis was more frequent 
compared to local recurrence. In advanced cases, 
it is important to make a diagnosis based on 
various symptoms, and chemoradiotherapy using 
platinum agents followed by adjuvant 
chemotherapy is recommended for squamous cell 
carcinoma cases.
3. Pharyngolaryngectomy and pharyngolaryngo-
esophagectomy for hypopharyngeal cancer [10]
A total of 37 hypopharyngeal cancer cases 
were treated by pharyngolaryngectomy and 
pharyngolaryngoesophagectomy at  the 
Department of Otolaryngology, Niigata 
University School of Medicine during an 18-year 
period between 1991 and 2008. The 37 cases 
comprised 31.4% of the total number of 
hypopharyngeal cancer cases during the study 
period. The mean patient age was 65 years (range 
39-83 years), and the proportion of males was 
94.6%. Histopathological analysis revealed that 
Figure 4. Prognosis of oral cancer according to the subsites.
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all cases were squamous cell carcinomas and the 
most common disease stage was IVA, followed 
by III, II, and IVB. Of the surgical procedures, 
62.2% were pharyngolaryngectomies and 37.8% 
pharyngolaryngoesophagectomies. Postoperative 
radiotherapy was administrated in 62.2% of the 
cases and chemotherapy in 40.5%. Although the 
recurrence rate was 37.8%, the disease-specific 
5-year survival rate of all cases was fair (58.5%). 
The prognosis of postoperative radiotherapy, 
which had been histopathologically indicated for 
high-risk cases, was not worse than that for non-
postoperative radiotherapy cases, suggesting that 
usefulness of postoperative radiotherapy for high-
risk cases. Local and cervical recurrence rates in 
the cases that underwent chemotherapy were 
significantly (p=0.046) lower than those in the 
cases treated without chemotherapy (Figure 6), 
which suggests the importance of a multi-faceted 
treatment strategy including chemotherapy.
4. Stage IV laryngeal cancer [11]
A total of 44 stage IV laryngeal cancer cases 
w e r e  t r e a t e d  a t  t h e  D e p a r t m e n t  o f 
Otolaryngology, Niigata University School of 
Medicine during a 19-year period between 1991 
Figure 5. Prognosis of nasopharyngeal cancer according to the stage. N.S.: not significant.
p
Figure 6. Prognosis of hypopharyngeal cancer cases that underwent pharyngolaryngectomy and 
pharyngolaryngoesophagectomy with and without chemotherapy. Cx: chemotherapy.
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and 2009. Stage IV cases was 16.8% of total 
laryngeal cancer cases and 77.3% of stage IV 
cases was supraglottic types. The disease-specific 
5-year survival rate of all stage IV cases was 
excellent at 67.2%. Since the differences between 
tumor stages below T3 and T4, and lymph node 
stages below N1 and above N2 were not 
statistically significant, positive treatment was 
useful even with advanced stage in both the 
larynx and neck. Laryngeal surgery resulted in no 
significant differences in prognosis, suggesting 
that the treatment choice was appropriate 
according to the stage of the larynx. The 
prognosis of cases that underwent neck dissection 
was significantly (p=0.032) better than that of 
those without neck dissection (Figure 7), 
indicating that neck with neck dissection was 
especially useful in cases with neck lymph nodes 
metastasis. Administration of radiotherapy and 
chemotherapy in histopathologically indicated 
high-risk cases had no statistical significance on 
prognosis, which suggested the usefulness of 
additional treatments in high-risk cases.
5. Ear cancer [12]
A total of 36 ear cancer cases were treated at 
the Department of Otolaryngology, Niigata 
University School of Medicine during a 17-year 
period between 1991 and 2007. The ear cancer 
cases represented 3.5% of the 1,032 total cases of 
head and neck cancer during the study period. 
The most common primary site was the external 
auditory canal (66.7%), followed by the middle 
ear (19.4%) and auricle (13.9%). The mean 
patient age was 65 years (range 29-84 years) and 
the ratio of male to female was 1.57. The most 
common complaint in external auditory canal and 
middle ear cancer cases was otorrhea (48.4%), 
followed by aural itching (29.0%) and otalgia 
(12.9%). A past history of ear surgery was 
reported in 25.8% of the cases and a habit of ear 
picking was observed in 35.5% of cases with 
external auditory canal and middle ear cancers. 
Under our treatment policy for indication of 
surgery as the first-line treatment followed by 
postoperative radiotherapy for cases with 
insufficient safety surgical margins, surgery was 
performed in 61.8% of all cases, and primary 
radiotherapy was administrated in 38.2%. Post 
operative radiotherapy was administrated in 
66.7% of the surgery cases. The 5-year survival 
rate of external auditory canal cancer was the 
highest at 73.6%, followed by auricular cancer at 
66.7%, and middle ear cancer at 34.3%. The 
surgery cases had an excellent 5-year survival 
rate at 82.4%, which was significantly (p=0.004) 
better than that of inoperable cases (28.6%) 
(Figure 8). However, no statistical significance 
p
Figure 7. Prognosis of stage IV laryngeal cancer cases with and without neck dissection. ND: neck 
dissection.
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was found between cases with and without 
postoperative radiotherapy in the surgical group. 
For ear cancer treatment, the high rate of surgery 
and the low number of cases refusing surgery was 
considered an important factor in the overall 
survival rate. Furthermore, postoperative 
radiotherapy seemed appropriate as a secondary 
treatment strategy.
6. Neck dissection [13]
Of a total of 131 neck cancer cases, 210 neck 
dissections were performed at the Department of 
Otolaryngology, Niigata University School of 
Medicine. The importance of neck dissection has 
been established in oral, mesopharyngeal, and 
hypopharyngeal cancer cases. Recurrence in the 
neck after neck dissection was observed in 8.4% 
of cases and mortality due to neck metastasis was 
relatively low (19.0%). The most common disease 
associated with neck recurrence was oral cancer; 
therefore, the area of neck dissection and 
additional postoperative treatment should be 
carefully evaluated in oral cancer cases. There 
was a statistically significant (p=0.0001) 
difference in pathological N stage scores, 
although there was none in preoperative N stage 
scores in cases treated with or without 
postoperative radiotherapy (Figure 9), suggesting 
the importance of indicating postoperative 
radiotherapy. The prognosis of metastatic cases 
p
Figure 8. Prognosis of operable and inoperable ear cancer cases.
p
Figure 9. Prognosis of neck dissection according to positive and negative pathological node metastasis 
without postoperative radiotherapy. pN: pathological node metastasis.
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with involvement of more than 2 lymph nodes 
was significantly poorer than cases with fewer 
than single metastatic lymph node; therefore, 
postoperative treatment is recommended for cases 
with more than 2 metastatic lymph nodes.
Conclusion
Since the incidence of head and neck cancer is 
low, its diagnosis tends to be late because of the 
lack of knowledge of head and neck cancer in 
patients. Wide resection surgery is often required 
for advanced-stage head and neck cancer; 
therefore, the selection of a reconstruction 
procedure is important. The choice of a treatment 
modality is difficult in neck cancer and local 
lesion because of the high incidence of neck 
lymph node metastasis [14] and the occurrence of 
functional complications in respiration, 
swallowing, and sensation. Therefore, a novel 
treatment strategy should be considered for the 
preservation of quality of life without diminishing 
the prognosis. Furthermore, since head and neck 
cancer patients have a higher incidence of 
multiple malignancies [3-5], treatment strategies 
and follow-up regarding early diagnosis of 
multiple malignancies are essential. Lastly, 
further analyses of the Niigata Prefecture Head 
and Neck Malignant Tumor Registration 
Committee and Niigata University database 
concerning for better cooperation of the hospitals 
based on the clinical character of each hospitals 
in Niigata Prefecture are necessary to keep 
abreast of advances in head and neck cancer 
treatment in Niigata Prefecture, Japan.
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